Pfizer Generates $2.88 Billion by Selling Off Hundreds of Millions of Haleon Shares

Pfizer's Share Sale:
Pfizer has sold a significant portion of its shares in Haleon, generating approximately $2.88 billion (2.4 billion pounds sterling).

Reduction in Stake:
This sale reduces Pfizer's total interest in Haleon from approximately 22.6% to 15.0%.

Buyback Details:
The purchase price per share in the buyback is 380 pence, with settlement expected on October 3, 2024.

Previous Similar Move:
This is not the first time Pfizer has offloaded Haleon shares; a similar move was made in March 2024.

Financial Impact:
The sale is part of Pfizer's strategy to manage its investments and generate significant capital.